Cases
Experience: Issuer's Counsel: Represented BioXcel Therapeutics, Inc. (NASDAQ: BTAI) in its $60 million initial public offering
Represented Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) in its $26 million initial public offering
Represented Hoth Therapeutics, Inc. (NASDAQ: HOTH) in its initial public offering
subsequent follow on offerings
Represented Workhorse Group, Inc. (NASDAQ: WKHS) in connection with its $35 million credit facility
term loan with Marathon Asset Management.
Represented Synergy Pharmaceuticals, Inc. in its $125 million follow-on public offering
Represented Synergy Pharmaceuticals, Inc. in its $200 million Convertible Note Rule 144A offering
Represented Synergy Pharmaceuticals, Inc. in its $17.25 million public offering
uplisting to Nasdaq, as well as a subsequent $51 million public offering
Represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) in its $7 million follow-on offering, as well as its subsequent $12 million follow-on offering
Represented Genprex, Inc. (NASDAQ: GNPX) in its $17.5 million registered direct offering
Represented Immune Pharmaceuticals, Inc. in its $18 million follow-on public offering
Represented Synergy Pharmaceuticals, Inc. in its $50 million At-the-Market offering with Cantor Fitzgerald & Co.
Represented ContraVir Pharmaceuticals, Inc. in its $50 million At-the-Market offering with Cantor Fitzgerald & Co.
Represented Astrotech Corp. (NASDAQ: ASTC) in its $8 million At-the-Market offering with B. Riley FBR, Inc.
Underwriter's Counsel: Represented The Benchmark Company, LLC
FT Global Capital, Inc. as underwriter in connection with a follow on public offering of $62 million of American depositary shares (ADSs) of Wimi Hologram Cloud, Inc. (NASDAQ: WIMI)
Represented WestPark Capital, Inc. as underwriter in connection with a $16 million Initial Public Offering of American depositary shares (ADSs) of AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC)
Represented Ladenburg & Co., Inc. in connection with a $16.5 million follow on public offering of Jaguar Health, Inc. (NASDAQ: JAGX).
Represented The Benchmark Company, LLC
ViewTrade Securities, Inc. in a $30 million at-the-market offering of India Globalization Capital, Inc.
Represented Laidlaw & Company (UK) Ltd. as underwriter in connection with a $24 million Initial Public Offering of Viking Therapeutics, Inc. (NASDAQ: VKTX)
Represented Laidlaw & Company (UK) Ltd. as underwriter in connection with a $18.5 million Initial Public Offering of PhaseRx Inc. (NASDAQ: PZRX)
Represented Maxim Group LLC, as representative of the underwriters, in connection with a $9 million follow on offering of common stock
warrants
uplisting to NASDAQ for MYnd Analytics, Inc.
Investors' Counsel: Represented Arena Investors LP in connection with its investment in Chanticleer Holdings, Inc. (NASDAQ: BURG).
Represented Arena Investors LP in connection with its investment in GOIP Global, Inc.
Represented Amzak Health Investors LLC
Acorn Bioventures LP in connection with its investment in Regulus Therapeutics, Inc. (NASDAQ: RGLS)
Represented Amzak Health Investors LLC in connection with its investment in GTx, Inc. (NASDAQ: GTXI)
Represented Amzak Health Investors LLC in connection with its investment in Selecta Biosciences, Inc. (NASDAQ: SELB)
Represented Ionic Ventures LLC in connection with its investment in Dthera Sciences, Inc.
Mergers
Acquisitions: Represented Avant Diagnostics, Inc. in connection with the sale of substantially all of its assets to OncBioMune Pharmaceuticals, Inc.
Represented RCX Capital Group, Inc. in connection with its joint venture with Ensenia Wealth, LLC.
Represented Baker Technologies, Inc. in connection with its business combination with Briteside Holdings, LLC, Sea Hunter Therapeutics, LLC
Sante Veritas Holdings Inc. to form TILT Holdings Inc.
its subsequent private placement of $119M
listing on the Canadian Securities Exchange.
Represented Datum Corporation in connection with the sale of substantially all of its assets to Datum Technologies, LLC
Represented Synergy Pharmaceuticals, Inc. in connection with its spin off of ContraVir Pharmaceuticals, Inc.
Represented Synergy Pharmaceuticals, Inc. in connection with its merger with Callisto Pharmaceuticals, Inc.
Represented interclick, inc. in connection with its acquisition by Yahoo, Inc.
Represented SinoEnergy Corporation in connection with its going private transaction.
* Includes some matters prior to joining SheppardMullin
